等待开盘 11-04 09:30:00 美东时间
+1.720
+0.66%
今日重点评级关注:康托·菲茨杰拉德:维持Cabaletta Bio"超配"评级,目标价从15美元升至30美元;HC Wainwright & Co.:维持Invivyd"买入"评级,目标价从5美元升至10美元
11-03 20:20
Keybanc analyst Ken Newman maintains WESCO Intl (NYSE:WCC) with a Overweight and raises the price target from $258 to $300.
10-31 21:15
科技巨头豪赌AI!5000亿美元投资涌向数据中心产业链,除了英伟达以外,美股还有哪些公司在“闷声发大财”?>>
10-31 17:17
U.S. stocks were mixed, with the Dow Jones index gaining around 200 points on T...
10-30 22:19
Companies Reporting Before The Bell • Altria Group (NYSE:MO) is projected to re...
10-30 19:12
WESCO Intl (NYSE:WCC) narrows FY2025 Adj EPS guidance from $12.00-$14.50 to $13.10-$13.60 vs $13.25 analyst estimate..
10-30 18:04
WESCO Intl (NYSE:WCC) reported quarterly earnings of $3.92 per share which beat the analyst consensus estimate of $3.83 by 2.24 percent. This is a 9.5 percent increase over earnings of $3.58 per share from the same
10-30 18:01
今日重点评级关注:Roth Capital:维持Cingulate"买入"评级,目标价从10美元升至17美元;JMP证券:维持BioCryst Pharma"跑赢大市"评级,目标价从17美元升至27美元
10-16 10:43
JP Morgan analyst Stephen Tusa maintains WESCO Intl (NYSE:WCC) with a Overweight and raises the price target from $225 to $245.
10-15 22:02
今日重点评级关注:富国银行:维持Kyverna Therapeutics"超配"评级,目标价从24美元升至27美元;Chardan Capital:维持Oculis Holding"买入"评级,目标价从33美元升至51美元
10-09 10:51